Variant report
Variant | esv3393635 |
---|---|
Chromosome Location | chr4:3861945-3862373 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551191969 | chr4:3861945-3861946 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs373086132 | chr4:3861957-3861958 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571197365 | chr4:3861962-3861963 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187443737 | chr4:3861963-3861964 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550632201 | chr4:3861971-3861972 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs28687289 | chr4:3861985-3861986 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs113159477 | chr4:3861990-3861991 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530953838 | chr4:3862000-3862001 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553591979 | chr4:3862028-3862029 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573363429 | chr4:3862054-3862055 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539075490 | chr4:3862061-3862062 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28522259 | chr4:3862072-3862073 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs115383838 | chr4:3862094-3862095 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144581202 | chr4:3862109-3862110 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs61235913 | chr4:3862129-3862130 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573589509 | chr4:3862186-3862187 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542522653 | chr4:3862204-3862205 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs28585974 | chr4:3862247-3862248 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs528299517 | chr4:3862253-3862254 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73088797 | chr4:3862259-3862260 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs28663407 | chr4:3862272-3862273 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs193263090 | chr4:3862287-3862288 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550590650 | chr4:3862299-3862300 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565533474 | chr4:3862315-3862316 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs148483604 | chr4:3862339-3862340 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141906726 | chr4:3862354-3862355 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536166683 | chr4:3862368-3862369 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Retinitis pigmentosa | 18421352 | CNVD |
Wolf-Hirschhorn syndrome | 19259404 | CNVD |
Bladder cancer | 19242612 | CNVD |
Breast cancer | 19242612 | CNVD |
Congenital anomalies of the kidney and urinary tract | 19242612 | CNVD |
abnormal development | 18461090 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 21544195 | CNVD |
Melanoma | 20688739 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Lung cancer | 18438408 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:3854600-3863800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr4:3855000-3863600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr4:3855800-3863600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
4 | chr4:3860000-3863400 | Weak transcription | H9 Cell Line | embryonic stem cell |
5 | chr4:3860400-3863400 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr4:3860400-3864800 | Weak transcription | Right Atrium | heart |
7 | chr4:3861000-3864400 | Weak transcription | Spleen | Spleen |
8 | chr4:3861600-3864000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr4:3861800-3863000 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
10 | chr4:3861800-3864000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr4:3862000-3862200 | Bivalent Enhancer | Skeletal Muscle Female | skeletal muscle |